tiprankstipranks
Avadel Pharmaceuticals (AVDL)
NASDAQ:AVDL
Holding AVDL?
Track your performance easily

Avadel Pharmaceuticals (AVDL) Financial Statements

675 Followers

Avadel Pharmaceuticals Financial Overview

Avadel Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.772; its P/E ratio is -13.35; Avadel Pharmaceuticals is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.03. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 50.02M$ 41.50M$ 27.18M$ 19.45M$ 7.01M
Gross Profit$ 43.87M$ 38.72M$ 25.66M$ 18.76M$ 6.90M
EBIT$ 283.00K$ -11.62M$ -24.66M$ -26.53M$ -34.21M
EBITDA$ 1.32M$ -11.18M$ -24.12M$ -26.53M$ -33.61M
Net Income Common Stockholders$ -2.63M$ -13.82M$ -27.34M$ -28.79M$ -36.27M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 65.81M$ 71.38M$ 88.79M$ 105.11M$ 153.18M
Total Assets$ 158.25M$ 157.52M$ 167.90M$ 164.70M$ 203.10M
Total Debt$ 1.94M$ 2.17M$ 2.40M$ 2.62M$ 24.03M
Net Debt$ -63.87M$ -69.21M$ -86.39M$ -102.49M$ -129.15M
Total Liabilities$ 83.59M$ 87.23M$ 89.52M$ 76.96M$ 92.95M
Stockholders Equity$ 74.66M$ 70.29M$ 78.38M$ 87.74M$ 110.15M
Cash Flow-
Free Cash Flow$ -6.89M$ -18.19M$ -29.70M$ -28.03M$ -38.23M
Operating Cash Flow$ -6.89M$ -18.19M$ -29.70M$ -28.03M$ -38.23M
Investing Cash Flow$ 4.93M$ 10.55M$ 21.39M$ 27.93M$ 9.82M
Financing Cash Flow$ 1.18M$ 723.00K$ 13.19M$ -21.11M$ 30.46M
Currency in USD

Avadel Pharmaceuticals Earnings and Revenue History

Avadel Pharmaceuticals Debt to Assets

Avadel Pharmaceuticals Cash Flow

Avadel Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis